AEON BIOPHARMA INC (AEON) Stock News
NYSEARCA:AEON - American Stock Exchange - US00791X1000 - Common Stock
AEON Latest News and Analysis
Top movers in Monday's after hours session
Monday's after hours session: top gainers and losers
Get insights into the top gainers and losers of Friday's after-hours session.
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
What's going on in today's session
Which stocks are experiencing notable movement on Friday?
Friday's session: gap up and gap down stocks
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Which stocks are most active on Thursday?
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Top movers in Thursday's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
These stocks have an unusual volume in today's session
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
These stocks have an unusual volume in today's session
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Unusual volume stocks in Wednesday's session
Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
In today's session, these stocks are experiencing unusual volume.
Unusual volume stocks in Tuesday's session
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused...
These stocks are moving in today's session
Which stocks are experiencing notable movement on Monday?
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
These stocks are moving in today's pre-market session
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company...
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
– Held biosimilar advisory meeting with FDA in Q3 2024, and aligned on next steps for a 351(k) regulatory pathway to approval for ABP-450...
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
IRVINE, Calif., Aug. 19, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company...
AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024
AEON stock results show that AEON Biopharma beat analyst estimates for earnings per share the second quarter of 2024.
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Progressing plans to develop ABP-450 (prabotulinumtoxinA) injection as a biosimilar utilizing BOTOX® (onabotulinumtoxinA) as the reference product – –...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
AEON Stock Earnings: AEON Biopharma Misses EPS for Q1 2024
AEON stock results show that AEON Biopharma missed analyst estimates for earnings per share the first quarter of 2024.
AEON Biopharma Reports First Quarter 2024 Financial Results
– Ongoing analysis of interim data from the Phase 2 study of ABP-450 in chronic migraine, which did not achieve its primary or secondary endpoints – –...
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
– Trial did not meet primary endpoint –...
Oversold Conditions For Aeon Biopharma (AEON)
AEON Stock Earnings: AEON Biopharma Reported Results for Q4 2023
AEON Biopharma just reported results for the fourth quarter of 2023.
CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants
IRVINE, Calif., March 30, 2024 (GLOBE NEWSWIRE) -- Regarding a release issued under the same headline on March 29, 2024 by AEON Biopharma, Inc. (NYSE:...
AEON Biopharma Announces Redemption of Public Warrants
IRVINE, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON; AEON.WS) (“AEON” or “the Company”), a clinical-stage...